Fc Fusion Protein Market Production Capacity Estimate and Forecast to 2030 |Industry Size,Trend,Growth and Future Demand
Increasing usage of Fc fusion protein for in vivo and in vitro research and increasing use as drugs are some key factors driving global Fc fusion protein market
VANCOUVER, BRITISH COLUMBIA, CANADA, February 1, 2023 /EINPresswire.com/ -- The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a revenue CAGR of 10.5% during the forecast period, according to latest analysis by Emergen Research. Increased use of Fc fusion proteins for in vivo and in vitro research, as well as increased use as drugs are key factors expected to drive robust market revenue growth over the forecast period. Increasing use of Fc fusion protein for vaccines is also expected to contribute significantly to revenue growth of the market between 2021 and 2028. Vaccination is becoming more important as the prevalence of infectious diseases rises around the globe. Increased use of Fc fusion protein for vaccines such as Filovirus vaccines is expected to boost market growth going ahead. In rabbits, mice, and monkeys, the immunogenicity of a CHO-expressed recombinant SARS-CoV-2 S1-Fc fusion protein as a potential COVID-19 vaccine option was studied.
However, Fc fusion protein is subject to stringent regulations when it is sold or used in clinical studies, which is a key factor expected to hamper growth of the global Fc fusion protein market to some extent in the near future. In addition, side effects of recombinant Eloctate with Fc fusion protein, which is used for treating hemophilia, is a factor expected to restrain market revenue growth to some extent.
Examples of Fc-fused binding partners include, but are not limited to, single peptides, ligands activated upon cell-surface receptor binding, signalling molecules, extracellular domains of a receptors activated upon dimerization and bait proteins used to identify binding partners in protein microarrays.
Download a PDF with Detail Analysis @ https://www.emergenresearch.com/request-sample/816
Key Highlights from the Report
Eye diseases segment revenue is expected to expand at a significantly rapid CAGR during the forecast period due to rising usage of Fc fusion protein for treating retinal diseases.
Biosimilar drugs segment is expected to register a significantly robust revenue growth rate over the forecast period. Fc fusion protein biosimilars have been utilized in a variety of clinical trials for cancer, chronic inflammatory disorders, HIV/AIDS, and other chronic diseases.
Major companies in the market report include Sanofi S.A., Bristol-Myers Squibb Company, Amgen Inc., Pfizer Inc., Swedish Orphan Biovitrum AB, Eli Lilly and Company, Astellas Pharma Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., and 3SBio Inc.
Quick Buy Hypersonic Technology Market : https://www.emergenresearch.com/select-license/816
Emergen Research has segmented the global Fc fusion protein on the basis of type, therapeutic area, application, end-use, and region:
Type Outlook (Revenue, USD Billion; 2018–2028)
Biosimilar Drugs
Brands Drugs
Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
Eye Diseases
Hemophilia
Autoimmune Disease
Diabetes
Others
Application Outlook (Revenue, USD Billion; 2018–2028)
In Vitro
Immunohistochemistry
Flow Cytometry
Binding Assays
Microarray Technologies
In Vivo
Bio-therapeutic Drugs
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Ophthalmic Hospitals
Oculoplastic Clinics
Regional Outlook (Revenue, USD Billion; 2018–2028)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/816
Look Over transcripts provided by Emergen Research
Surgical Robotics Market
Virtual Cardiology Market
Womens Health Market
Active Psoriatic Arthritis Market
Clinical Decision Support Systems Market
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
